Leap Therapeutics Inc (LPTX)
2.65
-0.09
(-3.28%)
USD |
NASDAQ |
May 17, 16:00
2.65
0.00 (0.00%)
After-Hours: 20:00
Leap Therapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.00 |
Date | Value |
---|---|
December 31, 2020 | 0.00 |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Mar 2020
--
Maximum
Mar 2020
--
Average
--
Median
Mar 2020
Debt to Equity Ratio Benchmarks
Cutera Inc | -2.177 |
OrthoPediatrics Corp | 0.0278 |
AIM ImmunoTech Inc | 0.00 |
Protalix BioTherapeutics Inc | 0.6856 |
Armata Pharmaceuticals Inc | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 57.96M |
Total Liabilities (Quarterly) | 10.59M |
Shareholders Equity (Quarterly) | 47.37M |